I’m looking forward to the upcoming AACR meeting at the Washington Convention Center Saturday through Wednesday. Like many of you, I plan to attend the meeting and Lombardi investigators are well-represented in posters and presentations. To make it easier to find your colleagues, a full list of oral and poster presentations and their locations and times is pasted at the end of this post. You can also view them in a Printable itinerary or Mobile itinerary.
I had a very interesting meeting with Dr. Reinhard Krepler who is the CEO of the Vienna General Hospital (AKH), which serves as Vienna’s university hospital. With 2141 beds, it is one of the largest hospitals in Europe. Dr. Krepler is interested in establishing a comprehensive cancer center along the lines of the US model and is touring various cancer centers here to understand how to proceed. Talking with him drove home the immense complexity and quality of comprehensive cancer centers (as if I didn’t know that from our CCSG!). Despite the remarkable patient population and general excellence of his hospital, it will likely take five to ten years of hard work for that hospital to emerge as a full-fledged comprehensive cancer center. It’s a sobering thought, but we can take pride in all that Lombardi has accomplished over the years. It’s easy to take our excellence for granted. Dr. Krepler’s visit was a useful reminder to the contrary.
Speaking of the CCSG, we’ve been asked by the NCI to provide the additional documentation related to our comprehensiveness review. This is a prelude to our notice of grant award, but nobody knows what the award amount will be.
Click through for a list of the AACR presentations.
Lombardi @ AACR
| Session Start Time Presentation Time Location |
Pres # & Type |
Poster Board # | Authors & Institutions | Abstract Title Session # & Title |
|
| Sat 4/17 10:00 AM 10:00 AM – 12:00 PMRoom 149, Washington Convention Center |
Special Session | Louis M. Weiner. Georgetown Lombardi Comp. Cancer Ctr., Washington, DC | FacultySS05.Cancer Immunology for the Non-Immunologist – Tutorial | ||
| Sun 4/18 2:00 PM 2:00 PM – 5:00 PMExhibit Hall A-C, Poster Section 2 |
66 Poster Session |
4 | Geetaram Sahu, Olga Catalina Rodriguez, Vamsi Kolukula, Jason Catania, Anju Preet, Arslaan Arshed, Christopher Albanese, Maria L. Avantaggiati. Georgetown University, Washington DC, DC | Corruption of the activity of the mitochondria citrate transporter, CIC, by mutant forms of p53PO.CB09.02.Cancer Cell Metabolism 2 | |
 |
Sun 4/18 2:00 PM 2:00 PM – 5:00 PMExhibit Hall A-C, Poster Section 3 |
116 Poster Session |
28 | Tytus Mak1, John B. Tyburski1, John F. Kalinich2, Albert J. Fornace, Jr.1. 1Georgetown University Medical Center, Washington, DC; 2Armed Forces Radiobiology Research Institute, Uniformed Services University, Bethesda, MD | A novel methodology for analyzing post-processed LC/MS metabolomics dataPO.CB11.02.Cancer Genomics and Bioinformatics 1 |
|
Sun 4/18 2:00 PM 2:00 PM – 5:00 PMExhibit Hall A-C, Poster Section 6 |
192 Poster Session |
22 | Shankar Jagadeesh1, Bikas C. Pal2, Samir Bhattacharya3, Partha P. Banerjee1. 1Georgetown Univ. Medical Ctr., Washington, DC; 2IICB, Kolkata, India; 3Visva-Bharati University, Santiniketan, India | Restoration of an epigenetically silenced tumor suppressor gene RASSF1A in human prostate cancer cells by a plant alkaloid, mahaninePO.CB06.05.DNA Methylation 2 |
|
Sun 4/18 2:00 PM 2:00 PM – 5:00 PMExhibit Hall A-C, Poster Section 11 |
327 Poster Session |
8 | Clarissa Torresan1, Savana C. Santos2, Jordi Camps3, Silma F. Pereira1, Enilze M. Ribeiro2, Iglenir J. Cavalli2, Bassem R. Haddad1, Luciane R. Cavalli1. 1Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC; 2Genetics Department, Federal University of Parana, Curitiba, Brazil; 3Section of Cancer Genomics, Genetics Branch, National Cancer Institute, NIH, Bethesda, MD | Genomic profiling of sentinel lymph node breast cancer metastasisPO.CB03.03.Oncogenomics 1: Molecular Cytogenetics |
|
Sun 4/18 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 18 |
489 Poster Session |
5 | Olga A. Timofeeva1, Nadya Tarasova2, Honghe Wang2, Alan Perantoni2, Anatoly Dritschilo1. 1Georgetown University, Washington, DC; 2National Cancer Institute, Frederick, MD | Selective inhibitor of STAT1 sensitizes breast cancer cells to radiation therapy
PO.TB09.02.Modulators of Radiation and Photobiological Responses |
|
Sun 4/18 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 23 |
607 Poster Session |
4 | Joan S. Wambi1, Helen Kim2, V. Craig Jordan2. 1Fox Chase Cancer Ctr., Philadelphia, PA; 2Georgetown University-Lombardi Comprehensive Cancer Center, Washington, DC | Loss of pigment epithelium derived-factor (PEDF) is associated with breast cancer progression and antihormone drug resistance
PO.ET04.01.Mechanisms of Resistance 1: Targeted Therapeutics |
|
Sun 4/18 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 23 |
609 Poster Session |
6 | Ping Fan, Helen R. Kim, V. Craig Jordan. Lombardi Comprehensive Cancer Ctr., Washington, DC | Paradoxical actions of a c-Src inhibitor on estradiol-induced apoptosis in long-term estrogen deprivation breast cancer cells
PO.ET04.01.Mechanisms of Resistance 1: Targeted Therapeutics |
|
Sun 4/18 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 26 |
721 Poster Session |
28 | Joseph J. LaConti, Narayan Shivapurkar, Anju Preet, Sung E. Kim, Anna T. Riegel, Anton Wellstein. Lombardi Cancer Center, Georgetown University, Washington, DC | An anaplastic lymphoma kinase antibody targets pancreatic allografts, prevents the progression of pancreatic cancer, and induces changes in microRNA expression
PO.ET07.01.Targeting Receptors and Cell Surface Antigens |
|
Sun 4/18 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 30 |
792 Poster Session |
11 | Sheila Weinmann1, Reina Haque2, Bhaskar Kallakury3, Kathryn Richert-Boe1, Deborah Berry3, Stephen Van Den Eeden4. 1Kaiser Permanente Northwest Center for Health Research, Portland, OR; 2Kaiser Permanente Southern California Region, Pasadena, CA; 3Georgetown University Hospital, Washington, DC; 4Kaiser Permanente Northern California Region, Oakland, CA | Prognostic significance of four molecular markers in relation to fatal prostate cancer after prostatectomy
PO.CL01.01.Molecular Classification of Tumors |
|
Sun 4/18 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 36 |
945 Poster Session |
7 | Hongyan Yuan1, Geeta Upadhyay1, Yuzhi Yin1, Claire Pollock1, Levy Kopelovich2, Robert I. Glazer1. 1Georgetown Univ. Medical Ctr., Washington, DC; 2National Cancer Institute, NIH, Bethesda, MD | Sca-1 deficiency enhances the chemopreventive activity of a peroxisome proliferator-activated receptorγ (PPARγ) agonist
PO.PR01.01.Animal Models of Prevention 1 |
| Sun 4/18 6:00 PM 6:00 PM – 7:30 PM Congressional Hall A, Renaissance Washington Hotel |
Town Meeting | Louis M. Weiner. Georgetown Lombardi Comp. Cancer Ctr., Washington, DC | Chairperson
TM02.Cancer Immunology Working Group (CIMM) Town Meeting and Reception |
||
| Mon 4/19 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 39 |
LB-112 Late-Breaking Poster Session |
4 | Sawali R. Sudarshan, Xuefeng Liu, Richard Schlegel. Georgetown University, Washington, DC | The human papillomavirus type 16 E5 protein represses X-box binding protein 1 and cyclooxygenase-2 stress signaling in keratinocytes.
LBPO.CG01.Late-Breaking Research: Carcinogenesis |
|
|
Mon 4/19 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 39 |
LB-110 Late-Breaking Poster Session |
2 | Hye Jung Baek, Michael J. Pishvaian, Kwan Ho Cho, Bibhuti Mishra, E. Premkumar Reddy, Lopa Mishra, Sang Soo Kim. National Cancer Center, Goyang-Si, Korea, Republic of, Georgetown University, Washington, D.C., DC, Temple University, Philadelphia, PA | CDK4 activation is a key step in ELF alteration and haploinsufficeny of cdk4 prevents HCC formation in elf+/- mice
LBPO.CG01.Late-Breaking Research: Carcinogenesis |
|
Mon 4/19 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 5 |
1119 Poster Session |
29 | Tejaswita M. Karve, Saijun Fan, Eliot M. Rosen. Georgetown University, Washington, DC | Role of BTG2 in the antioxidant response in breast cancer cells
PO.CB04.02.Established Tumor Suppressor Genes 1 (Including RB1 and p53) |
|
Mon 4/19 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 11 |
1263 Poster Session |
11 | Shehla Wynne, Daniel Djakiew. Georgetown University Medical Center, Washington, DC | Induction of nonsteroidal anti-inflammatory drug-activated gene-1 (Nag-1) by NSAIDs: role of p75NTR
PO.CB02.02.The Canonical Pathways of Cell Death and Autophagy |
|
Mon 4/19 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 11 |
1279 Poster Session |
27 | V. Craig Jordan1, Eric A. Ariazi2, Heather E. Cunliffe3, Joan S. Lewis-Wambi2, Smitha Yerrum2, Helen R. Kim1, Catherine G.N. Sharma2, Amanda Willis3, Pilar Ramos3, Coya Tapia3, Michael J. Slifker2, Suraj Peri2, Eric A. Ross2. 1Lombardi Comprehensive Cancer Center, Washington, DC; 2Fox Chase Cancer Center, Philadelphia, PA; 3Translational Genomics Research Institute, Phoenix, AZ | Caspase-4 is critical in estrogen-induced apoptosis in antihormone-resistant breast cancer
PO.CB02.02.The Canonical Pathways of Cell Death and Autophagy |
|
Mon 4/19 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 13 |
1323 Poster Session |
15 | Kamal Datta, Michael D. Johnson, Daniel Hyduke, Daniela Trani, Bhaskar Kallakury, Kathryn Doiron, Albert J. Fornace, Jr.. Georgetown University, Washington, DC | Sustained activation of proliferative pathways and increased mammary gland tumorigenesis with γ radiation: A mouse model study
PO.TB09.01.DNA Damage Response, Signaling, and Gene Expression |
|
Mon 4/19 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 20 |
1491 Poster Session |
23 | Hong Cao, Ying Li, Wenguo Yao, Wilma Jogunoori, Arun Thenappan, Lopa Mishra. Georgetown University, Washington, DC | CEA interacts with TGF-β receptor and inhibits TGF-β signaling in colorectal cancers
PO.CG01.03.Molecular Analysis of Carcinogenesis |
|
Mon 4/19 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 23 |
1550 Poster Session |
3 | Gulay Bulut1, Kevin Chen1, Eric Glasgow1, Sung-Hyeok Hong2, Hyun-Shik Lee3, George Kosturko1, Jeffrey A. Toretsky1, Ira Daar3, Chand Khanna2, Aykut Uren1. 1Georgetown Lombardi Comp. Cancer Ctr., Washington, DC; 2National Cancer Institute, Bethesda, MD; 3National Cancer Institute, Frederick, MD | Small molecule inhibitors of ezrin as anti-metastatic agents in osteosarcoma
PO.ET06.09.Metastasis and Tumor-Host Interactions |
|
Mon 4/19 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 25 |
1629 Poster Session |
29 | Xiantao Wang, Sudha Govind, Jessie Yu-Chieh Wu, York Tomita, Lixin Mi, Anthony J. Di Pasqua, Fung-Lung Chung. Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC | Restoration of the wild type function to mutant p53 by chemopreventive agent phenethyl isothiocyanate
PO.ET02.04.New Molecular Targets 4: Identification of Molecular Targets II |
|
Mon 4/19 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 28 |
1694 Poster Session |
8 | Fung-Lung Chung, Mona Y. Wu, Marcin D. Dyba, Raghu G. Nath. Georgetown Lombardi Comp. Cancer Ctr., Washington, DC | Selective formation of the γ isomer of 1,N2-propanodeoxyguanosine adducts of acrolein through interactions with amine-containing molecules
PO.CH04.01.Mechanisms of Carcinogenesis |
|
Mon 4/19 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 30 |
1737 Poster Session |
9 | Jeffrey S. Ross1, Christine E. Sheehan1, Bhaskar V.S. Kallakury2. 1Albany Medical College, Albany, NY; 2Georgetown University Hospital, Washington, DC | Lipocalin-2/NGAL expression is associated with poor prognostic variables in human mammary, endometrial and ovarian carcinomas
PO.CL13.04.Biomarkers of Metastasis |
| Mon 4/19 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 2 |
2014 Poster Session |
10 | Rochelle E. Nasto1, Ilya Serebriiskii2, Sandra A. Jablonski3, Michael D. Johnson3, Robert Clarke3, Louis M. Weiner3, Erica A. Golemis2. 1School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA; 2Fox Chase Cancer Center, Philadelphia, PA; 3Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC | An estrogen receptor – centered network for probing anti-estrogen drug resistance with siRNA screening technology
PO.CB14.01.Cancer Systems Biology and Integrative Analysis |
|
|
Mon 4/19 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 7 |
2158 Poster Session |
29 | Marcia Maria Costa de Oliveira1, Luciane R. Cavalli2, Cícero Andrade Urban3, Rubens Silveira de Lima3, Enilze Maria de Souza Fonseca Ribeiro1, Iglenir João Cavalli1. 1Federal University of Parana, Curitiba – Parana, Brazil; 2Georgetown University Medical Center, Washington, DC; 3Hospital Nossa Senhora das Graças, Curitiba – Parana, Brazil | Loss of heterozygosity at chromosome 3p in ductal and lobular breast carcinomas
PO.CB10.03.Oncogenomics 2: Copy Number Alterations |
|
Mon 4/19 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 23 |
2547 Poster Session |
4 | Nadia Jafar, Ayesha N. Shajahan, Robert Clarke. Lombardi Cancer Center, Georgetown University, Washington, DC | Caveolin-1 inhibits survivin and increases sensitivity to paclitaxel in breast cancer cells
PO.ET04.03.Mechanisms of Resistance 3: Chemotherapeutics |
|
Mon 4/19 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 25 |
2613 Poster Session |
16 | Zacharoula Konsoula, Alfredo Velena, Hong Cao, Mira Oh Jung. Georgetown Lombardi Comp. Cancer Ctr., Washington, DC | Assessment of pharmacokinetics-pharmacodynamics and antitumor activities of hydroxamate- and mercaptoacetamide-based histone deacetylase inhibitors
PO.ET05.02.Pharmacogenomics and Personalized Medicine 2 |
|
Mon 4/19 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 28 |
2681 Poster Session |
14 | Julie S. Barber-Rotenberg1, Yali Kong1, Nilan Schnure1, Sivanesan Dakshanamurthy1, Peter Frazier2, Hayriye V. Erkizan1, Milton L. Brown1, Aykut Uren1, Jeffrey A. Toretsky1. 1Georgetown University, Washington, DC; 2Cornell University, Ithaca, NY | EWS-FLI1 as a molecular target: Small molecule inhibitors for a disordered protein
PO.CH02.01.Structural Biology and Drug Design |
|
Mon 4/19 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 30 |
2684 Poster Session |
3 | Xin Zhou1, Alan Meeker2, Bhaskar Kallakury3, Mary Sidawy3, Christopher Loffredo1, Yun-Ling Zheng1. 1Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC; 2Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD; 3Department of Pathology, Georgetown University, Washington, DC | Telomere length of carcinoma-associated fibroblasts as a biomarker for breast cancer local recurrence
PO.CL13.01.Biomarkers Predictive of Response to Therapy 1 |
|
Mon 4/19 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 34 |
2794 Poster Session |
19 | Ourania Kosti1, Lenka Goldman1, Ionut Bebu1, Ann Hsing2, Sean Collins3, Anatoly Dritschilo3, John Lynch3, Xia Xu4, Timothy Veenstra4, Radoslav Goldman1. 1Georgetown Univ., Washington, DC; 2National Cancer Institute, Rockville, MD; 3Georgetown University Hospital, Washington, DC; 4National Cancer Institute, Frederick, MD | Urinary estrogen metabolites and prostate cancer risk: A case control analysis using healthy and biopsy controls
PO.EP02.02.Circulating and Tumor Biomarkers in Relation to Cancer Risk |
|
Mon 4/19 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 37 |
2880 Poster Session |
20 | Ila Das1, Asha Acharya2, Archana Sengupta1, Shukta Das1, Sudin Bhattacharya1, Tapas Saha3. 1Chittaranjan National Cancer Institute, Kolkaka, India; 2GeneTarn Corporation, Rockville, MD; 3Georgetown University, Washington, DC | Spices suppress oxidative stress during DMBA induced skin carcinogenesis in mice, mimicking human non-melanoma skin cancer
PO.PR01.02.Animal Models of Prevention 2 |
|
Mon 4/19 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 37 |
2888 Poster Session |
28 | Wei Yu1, Larry G. Maxwell2, Mark Cline3, David Berrigan4, Gustavo Rodriguez5, Anni Warri1, Leena Hilakivi-Clarke1. 1Georgetown University, Washington, DC; 2Gynecologic Disease Center, Walter Reed, Washington, DC; 3Wake Forest University School of Medicine, NC, Winston-Salem, NC; 4National Cancer Institute, Bethesda, MD; 5Northwestern University, Chicago, IL | Vitamin D inhibits obesity-induced endometrial carcinogenesis in Pten+/- mice
PO.PR01.02.Animal Models of Prevention 2 |
|
Mon 4/19 2:30 PM 2:30 PM – 5:00 PM Room 103, Washington Convention Center |
Minisymposium | V. Craig Jordan. Lombardi Comprehensive Cancer Ctr., Washington, DC | Chairperson
MS.EN01.01.Steroid Receptor Targets and Preclinical Therapies in Cancer |
|
|
Mon 4/19 2:30 PM 3:25 PM – 3:40 PM Room 103, Washington Convention Center |
2919 Minisymposium |
Ayesha N. Shajahan, Rebecca B. Riggins, Alan Zwart, F. Edward Hickman, Robert Clarke. Georgetown University, Washington, DC | XBP1 and the unfolded protein response in antiestrogen resistance in breast cancer
MS.EN01.01.Steroid Receptor Targets and Preclinical Therapies in Cancer |
|
| Mon 4/19 3:30 PM 3:45 PM – 3:55 PM Room 146, Washington Convention Center |
LB-172 Minisymposium: Late-Breaking Research |
Kathleen F. Pirollo, John J. Nemunaitis, Neil N. Senzer, Leanne Sleer, Esther H. Chang. Lombardi Comp. Cancer Ctr. at Georgetown Univ., Washington, DC, Mary Crowley Medical Research Center, Dallas, TX, SynerGene Therapeutics, Inc, Potomac, MD | Transgene presence in patients’ tumors following tumor-targeted nanodelivery
LBMS01.Clinical Trials |
||
| Mon 4/19 2:30 PM 4:25 PM – 4:40 PM Room 201, Washington Convention Center |
2931 Minisymposium |
Sonia de Assis, M. Idalia Cruz, Anni Warri, Leena Hilakivi-Clarke. Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC | Exposure of rat dams to a high-fat or estradiol-supplemented diet during pregnancy alters mammary gland morphology and increases mammary cancer risk in their daughters and granddaughters
MS.PR01.01.New Markers and Models for Cancer Prevention |
||
| Mon 4/19 6:30 PM 6:30 PM – 8:30 PM Ballroom A-B, Renaissance Washington Hotel |
Professional Advancement Series Session | Lucile L. Adams-Campbell. Georgetown Lombardi Comp. Cancer Ctr., Washington, DC | Facilitator
PAS18.Professional Advancement Reception and Roundtable: Navigating the Road to a Successful Career in Cancer Research |
||
| Tue 4/20 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 4 |
3031 Poster Session |
7 | Catalin Marian, Ionut Bebu, Danesh Kella, Xin Zhou, Md Islam, Habtom Ressom, Peter Shields, Yun-Ling Zheng. Georgetown Univ. Medical Ctr., Lombardi Cancer Center, Washington, DC | Screening for plasma micro RNAs as biomarkers for breast cancer detection
PO.CB13.05.MicroRNA Profiling in Cancer 2 |
|
|
Tue 4/20 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 5 |
3079 Poster Session |
25 | Zhongxian Jiao1, Sanjeev Shukla1, Gyanendra Kumar1, Wenguo Yao1, Hong Cao1, Wilma SR Jogunoori1, Zhixing Yao1, Lopa Mishra2, Bibhuti Mishra1. 1Georgetown Univ., Washington, DC; 2University of Texas MD Anderson Cancer Center, Houston, TX | Loss of β2-spectrin may lead to the activation of telomerase reverse transcriptase (TERT) and hepatocellular cancer formation
PO.CB04.03.Novel Tumor Suppressor Genes 1 |
|
Tue 4/20 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 6 |
3114 Poster Session |
30 | Thanemozhi G. Natarajan1, Bhaskar V. Kallakury1, Christine Sheehan2, Margaret B. Bartlett1, Natarajan Ganesan1, Anju Preet1, Jeffrey Ross2, Kevin T. FitzGerald1. 1Georgetown Univ., Washington, DC; 2Albany Medical College, Albany, NY | MLL2 overexpression and incomplete proteolytic processing in human cell lines from invasive breast and colon cancers
PO.CB04.01.Nuclear Oncogenes |
|
Tue 4/20 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 13 |
3263 Poster Session |
10 | Claire B. Pollock1, Yuzhi Yin1, Hongyan Yuan1, Xiao Zeng1, Sruthi King1, Levy Kopelovich2, Robert I. Glazer1. 1Georgetown Lombardi Comp. Cancer Ctr., Washington, DC; 2National Cancer Institute, National Institutes for Health, Bethesda, MD | Acceleration of mammary tumorigenesis by PDK1 and peroxisome proliferator-activated receptorδ
PO.TB01.01.Animal Models of Breast and Ovarian Cancer |
|
Tue 4/20 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 15 |
3320 Poster Session |
7 | Kenneth Steadman1, Robert Robey2, Karen Creswell1, Rebecca Slack1, John Deeken1. 1Georgetown University Medical Center, Washington, DC; 2National Cancer Institute, Bethesda, MD | Head & neck cancer stem cells express drug resistance transporters but do not display a resistant phenotype
PO.TB02.03.Cancer Stem Cell Therapeutics 1 |
|
Tue 4/20 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 17 |
3387 Poster Session |
15 | Heng-Hong Li1, Qian Yang1, Yi-wen Wang1, Suzie Chen2, Albert J. Fornace, Jr.1. 1Georgetown Lombardi Comp. Cancer Ctr., Washington, DC; 2Rutgers Univ. Lab. for Cancer Research, Piscataway, NJ | Characterization of the role of the type 2C phosphatase Ppm1d (Wip1) in metastasis
PO.TB04.05.Mechanisms of Tumor Metastasis 2 |
|
Tue 4/20 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 18 |
3405 Poster Session |
6 | Miguel Sainz-Jaspeado1, Laura Lagares-Tena1, Jaime Lasheras1, Fariba Navid2, Carlos Rodriguez-Galindo2, Silvia Mateo-Lozano3, Vicente Notario4, Xavier Sanjuan1, Xavier Garcia del Muro1, Angels Fabra1, Oscar M. Tirado1. 1IDIBELL, Hospitalet de Llobregat, Spain; 2St. Jude Children’s Research Hospital, Memphis, TN; 3CIBBIM-Nanomedicine, Barcelona, Spain; 4Lombardi Comprehensive Cancer Center, Washington, DC | Caveolin-1 modulates the metastatic ability of Ewing’s sarcoma
PO.TB08.03.Pediatric Solid Tumors |
|
Tue 4/20 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 18 |
3409 Poster Session |
10 | Elspeth M. Beauchamp, Olga Rodriguez, Christopher Albanese, Jeffrey A. Toretsky, Aykut Üren. Georgetown Lombardi Comp. Cancer Ctr., Washington, DC | Arsenic trioxide inhibits Ewing sarcoma growth by blocking Hedgehog/GLI pathway
PO.TB08.03.Pediatric Solid Tumors |
|
Tue 4/20 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 18 |
3411 Poster Session |
12 | Jeffrey A. Toretsky1, Hayriye V. Erkizan1, Yali Kong1, Melinda Merchant2, Julie S. Barber-Rotenberg1, Milton L. Brown1, Aykut Üren1. 1Lombardi Comp. Cancer Ctr. at Georgetown Univ., Washington, DC; 2Pediatric Oncology Branch, National Institute of Health, Bethesda, MD | Targeting of EWS-FLI1 with small molecule YK-4-279 reduces xenograft growth by disruption of disordered protein-protein interactions
PO.TB08.03.Pediatric Solid Tumors |
|
Tue 4/20 9:00 AM 9:00 AM – 12:00 PM Exhibit Hall A-C, Poster Section 18 |
3412 Poster Session |
13 | Lauren M. Jacobwitz, Hayriye V. Erkizan, Aykut Üren, Jeffrey A. Toretsky. Lombardi Comp. Cancer Ctr. at Georgetown Univ., Washington, DC | Phage display identifies novel toxic binding peptides for the disordered oncoprotein EWS-FLI1
PO.TB08.03.Pediatric Solid Tumors |
|
Tue 4/20 10:30 AM 11:45 AM – 12:05 PM Room 152, Washington Convention Center |
New Concepts in Organ Site Research Session | Jeffrey A. Toretsky. Georgetown Lombardi Comp. Cancer Ctr., Washington, DC | Targeting sarcoma oncogenes with small molecule protein-protein interaction inhibitors
NC25.Sarcoma Genomics: Translating New Discoveries into Therapeutic Targets |
|
| Tue 4/20 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 40 |
LB-324 Late-Breaking Poster Session |
13 | Shangzi Wang, Wei Xu, Yong Tang, Rishi Surana, Catherine Bingham, Igor A. Astsaturov, Kenneth McCarthy, R. Katherine Alpaugh, Bruce A. Littlefield, Lynn D. Hawkins, Sally T. Ishizaka, Louis M. Weiner. Lombardi Comprehensive Cancer Center, Washington, DC, Fox Chase Cancer Center, Philadelphia, PA, Harvard Medical School, Boston, MA, Eisai Research Institute, Andover, MA | A toll-like receptor 4 agonist enhances the efficacy of trastuzumab therapy and promotes adaptive immunity and long-term protection against a human ErbB-2 (HER2)-transfected syngeneic tumor in a human HER2 transgenic mouse model
LBPO.IM01.Late-Breaking Research: Immunology |
|
|
Tue 4/20 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 37 |
LB-240 Late-Breaking Poster Session |
17 | Kyle A. DiVito, Valerie Trabosh, You-shin Chen, Delphine Javelaud, Alain Mauviel, Chris Albanese, Cynthia M. Simbulan-Rosenthal, Dean S. Rosenthal. Georgetown University School of Medicine, Washington, DC, INSERM U697, Paris, France | Smad7 blocks melanoma invasion by suppressing n-cadherin cleavage and preserving heterotypic cell-cell interactions in vivo
LBPO.CB04.Late-Breaking Research: Cellular and Molecular Biology 4 |
|
Tue 4/20 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 1 |
3884 Poster Session |
17 | Shaoxian Yang1, Majed El Zouhairi1, Sang S. Kim2, Lopa Mishra2, Michael J. Pishvaian1. 1Lombardi Cancer Center, Georgetown University, Washington, DC; 2Georgetown University, Washington, DC | Beta-2 spectrin opposes the CDK4-mediated suppression of TGF-beta signaling by rescuing Smad3 nuclear localization
PO.CB07.02.Cell Cycle 2 |
|
Tue 4/20 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 2 |
3897 Poster Session |
5 | Silke Schlottmann, Hayriye V. Erkizan, Julie Barber-Rotenberg, Aykut Uren, Maria L. Avantaggiati, Jeffrey A. Toretsky. Georgetown Lombardi Comp. Cancer Ctr., Washington, DC | EWS-FLI1 is regulated by acetylation
PO.CB05.02.Developmental Gene Expression Pathways |
|
Tue 4/20 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 2 |
3913 Poster Session |
21 | Ling Lin, Zhixing Yao, Arun Thenappan, Wilma S. Jogunoori, Lopa Mishra, Aiwu Ruth He. Georgetown University, Washington, DC | TGF-β signaling mediated suppression of stat3 transcription in hepatocellular cancer
PO.CB05.02.Developmental Gene Expression Pathways |
|
Tue 4/20 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 6 |
4018 Poster Session |
18 | David P. Kodack1, Joseph LaConti1, Masaharu Noda2, Anton Wellstein1. 1Georgetown Univ., Washington, DC; 2National Institute of Basic Biology, Okazaki, Japan | Crosstalk between the pleiotrophin-anaplastic lymphoma kinase axis and the protein tyrosine phosphatase ζ signaling pathways
PO.CB01.05.Intracellular Signaling 2 |
|
Tue 4/20 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 14 |
4214 Poster Session |
3 | Geeta Upadhyay1, Claire Pollock1, Yuzhi Yin1, Hongyan Yuan1, Levi Kopelovich2, Robert I. Glazer1. 1Georgetown University, Washington, DC; 2National Cancer Institute, Bethesda, MD | Stem cell antigen-1 (Sca1) modulates PI3K/PTEN signaling and mammary tumor cell survival
PO.TB02.05.Cancer Stem Cell Biology 1 |
|
Tue 4/20 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 15 |
4258 Poster Session |
17 | Ying Li, Wilma Jogunoori, Wenguo Yao, Hong Cao, Bibhuti Mishra, Lopa Mishra. Georgetown Univ., Washington, DC | Role of β2SP in asymmetric division and differentiation of intestine epithelial cells
PO.TB02.06.Cancer Stem Cell Biology 2 |
|
Tue 4/20 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 16 |
4274 Poster Session |
7 | Ola Awad1, Jason T. Yustein1, Preeti Shah1, Naheed Gul1, Julie B. Rotenberg2, Jeffrey Toretsky2, David Loeb1. 1Johns Hopkins Univ., Baltimore, MD; 2Georgetown University, Washington, DC | High aldehyde dehydrogenase activity identifies a chemotherapy-resistant population of ewing’s sarcoma cells with a stem cell phenotype that retains sensitivity to EWS-FLI1 inhibition
PO.TB02.04.Cancer Stem Cell Therapeutics 2 |
|
Tue 4/20 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 26 |
4521 Poster Session |
1 | Meilan Liu1, Chenxi Shen1, Martha Larsen2, Chao-Yie Yang3, Su Qiu3, York Tomita4, Krzysztof Krajewski5, Peter P. Roller5, Jeanne Stuckey2, Shaomeng Wang3, Zaneta Nikolovska-Coleska1. 1Department of Pathology, University of Michigan, Ann Arbor, MI; 2Life Sciences Institute, University of Michigan, Ann Arbor, MI; 3Departments of Internal Medicine, Pharmacology and Medicinal Chemistry and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI; 4Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC; 5Laboratory of Medicinal Chemistry, National Cancer Institute, National Institutes of Health, Frederick, MD | Discovery of novel small molecule inhibitors of the antiapoptotic protein Mcl-1 through high-throughput screening approach
PO.ET06.08.Tumor Metabolism and Regulation of Apoptosis |
|
Tue 4/20 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 29 |
4593 Poster Session |
4 | Matthew J. Sikora1, Michael D. Johnson2, James M. Rae1. 1University of Michigan, Ann Arbor, MI; 2Georgetown University, Washington, DC | Molecular characterization of the androgen metabolite 3βAdiol as a partial agonist of ERα
PO.EN01.01.Regulation of Estrogen Receptor-Positive and -Negative Breast Cancer |
|
Tue 4/20 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 29 |
4595 Poster Session |
6 | Mary M. Mazzotta, Minetta C. Liu, Robert Clarke, Rebecca B. Riggins. Georgetown Lombardi Comp. Cancer Ctr., Washington, DC | ERK/MAPK regulation of ERRγ in Tamoxifen resistant breast cancer
PO.EN01.01.Regulation of Estrogen Receptor-Positive and -Negative Breast Cancer |
|
Tue 4/20 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 29 |
4600 Poster Session |
11 | Omar Z. Maniya1, Alan Zwart1, Li Chen2, Jianhua Xuan2, Robert Clarke1, Rebecca B. Riggins1. 1Georgetown Lombardi Comp. Cancer Ctr., Washington, DC; 2Virginia Polytechnic Institute and State University, Arlington, VA | The role of COUP transcription factors in Tamoxifen resistant breast cancer cells
PO.EN01.01.Regulation of Estrogen Receptor-Positive and -Negative Breast Cancer |
|
Tue 4/20 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 29 |
4601 Poster Session |
12 | Lauren M. McDaniel, Ayesha N. Shajahan, Robert Clarke. Georgetown University, Washington, DC | XBP1 regulated function of c-MYC and BCL2 in antiestrogen resistance in breast cancer
PO.EN01.01.Regulation of Estrogen Receptor-Positive and -Negative Breast Cancer |
|
Tue 4/20 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 33 |
4701 Poster Session |
10 | Ramona G. Dumitrescu1, Yun-Ling Zheng2, Yang Yang2, Francoise Seillier-Moiseiwitsch2, Stephanie M. Spernak2, Christopher Loffredo2, David H. Phillips3, Peter G. Shields2. 1Saba University Medical School, Saba, Netherlands Antilles; 2Georgetown University Medical School, Washington, DC; 3Institute of Cancer Research, Surrey, United Kingdom | DNA-adducts levels and chromosomal aberrations in relation to smoking history and topography in smokers
PO.EP02.01.Exposure and Tumor Biomarkers in Cancer Risk and Survival |
|
Tue 4/20 2:00 PM 2:00 PM – 5:00 PM Exhibit Hall A-C, Poster Section 33 |
4706 Poster Session |
15 | Montero Santamaria Jose Angel1, Priscilla A. Furth1, Bhaskar V.S. Kallakury1, Ramona G. Dumitrescu1, Marian Catalin1, Scott L. Spear1, Jo L. Freudenheim2, Peter G. Shields1. 1Georgetown University, Washington, DC; 2University at Buffalo, Buffalo, NY | Gene and protein expression of TGF-beta signaling pathway molecules in women undergoing reduction mammoplasty
PO.EP02.01.Exposure and Tumor Biomarkers in Cancer Risk and Survival |
| Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 1 |
4833 Poster Session |
3 | Olga Catalina Rodriguez, Vamsi Kokula, Jason Catania, Anju Preet, Arslaan Arshed,, Michael Pishvaian, Christopher Albanese, Maria L. Avantaggiati. Georgetown University, Washington DC, DC | Glucose restriction induces degradation of p53 mutants via a selective autophagy-mediated pathway
PO.CB09.04.Autophagy |
|
|
Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 1 |
4857 Poster Session |
27 | Nesrin S. Rechache, Rebecca B. Riggins, Ayesha N. Shajahan, Alan Zwart, Robert Clarke. Georgetown Univ., Washington, DC | The role of autophagy in taxane resistant breast cancer models
PO.CB09.04.Autophagy |
|
Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 3 |
4912 Poster Session |
22 | Zhi-Xing Yao1, Wilma SR Jogunoori1, Sanjeev Shukla1, Wenguo Yao1, Bibhuti Mishra1, Lopa Mishra2. 1Georgetown Univ., Washington, DC; 2University of Texas MD Anderson Cancer Center, Houston, TX | The role of long-range enhancer blocker CTCF in TGF-β/β-2 spectrin signaling: A human cancer stem cell disorder, Beckwith-Wiedemann syndrome
PO.CB06.04.DNA Methylation 3 |
|
Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 6 |
4976 Poster Session |
15 | Insoo Bae1, Hyo Jin Kang1, Hee Jeong Kim1, Yong Bin Hong1, Young Soo Chang2. 1Georgetown University, Washington, DC; 2Dankook University, Chunan, Korea, Republic of | Crif1, a new negative regulator of Nrf2
PO.CB05.01.Mechanisms of Gene Expression |
|
Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 8 |
5023 Poster Session |
2 | Yanxia Ning1, Rebecca B. Riggins2, Ayesha N. Shajahan2, Alan Zwart2, Robert Clarke2. 1Shanghai Medical College, Fudan University, Shanghai, China; 2Georgetown University Medical Center, Washington, DC | Down-regulating interferon regulatory factor-1 by siRNA promotes endurance to fulvestrant in sensitive breast cancer cells partially via Ras/Raf/MEK/ERK pathway
PO.CB04.07.Oncogenes and Tumor Suppressor Genes 1: New Therapeutic Targets and Strategies |
|
Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 8 |
5047 Poster Session |
26 | Michael J. Pishvaian, Shaoxian Yang, Majed El Zouhairi, Christina S. Wu, Lopa Mishra, Maria-Laura Avantaggiati. Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC | Synergistic anti-cancer activity of the CDK4/6 inhibitor PD-0332991 in combination with 5-fluorouracil-based chemotherapy in human colon cancer cells
PO.CB04.07.Oncogenes and Tumor Suppressor Genes 1: New Therapeutic Targets and Strategies |
|
Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 10 |
5098 Poster Session |
17 | Anna L. Sukhanova1, Tetyana Bagnyukova1, Lisa E. Kratz2, Richard I. Kelley2, Ilya G. Serebriiskii1, Louis M. Weiner3, Erica A. Golemis1, Igor A. Astsaturov1. 1Fox Chase Cancer Center, Philadelphia, PA; 2Kennedy Krieger Institute, Johns Hopkins University, Baltimore, MD; 3Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC | Targeting the cholesterol pathway gene SC4MOL sensitizes cancer to EGFR inhibitors
PO.CB09.03.Signaling Pathways that Regulate Metabolism |
|
Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 10 |
5103 Poster Session |
22 | Amrita K. Cheema, Mira Jung, Olga Timofeeva, Rency Varghese, Habtom Ressom, Anatoly Dritschilo. Georgetown University, Washington, DC | Analysis of the role of “ATM” through “omics” analysis
PO.CB09.03.Signaling Pathways that Regulate Metabolism |
|
Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 11 |
5133 Poster Session |
22 | Eric M. Balzer1, Rebecca Whipple-Bettes1, Edward H. Cho1, Michael A. Matrone1, Susette C. Mueller2, Stuart S. Martin1. 1University of Maryland, Baltimore, Baltimore, MD; 2Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC | Microtentacles and invadopodia: Functionally distinct plasma membrane protrusions of metastatic breast tumor cells separated mechanistically by c-Src
PO.TB03.05.Adhesion and Cytoskeletal Signaling in Invasion |
|
Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 17 |
5271 Poster Session |
2 | Susan F. Murphy1, Magdalena Banasiak1, Gi-Taek Yee1, Marguerite Wotoczek-Obadia1, Menyoli Malafa1, Mumtaz V. Rojiani1, Amyn M. Rojiani1, Philip Tofilon1, Fraser Henderson2, Daniel Djakiew2, Peter A. Forsyth3, Donna L. Senger3, Steven Brem1. 1H. Lee Moffitt Cancer Ctr. & Res. Inst., Tampa, FL; 2Georgetown University Medical Center, Washington, DC; 3University of Calgary, and Tom Baker Cancer Centre, Calgary, AB, Canada | Ibuprofen, an inhibitor of angiogenesis, enhances radiosensitivity and suppresses glioma invasion: Role of p75NTR and VEGF
PO.TB03.06.Signaling in Tumor Cell Migration and Invasion 2 |
|
Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 20 |
5357 Poster Session |
11 | Keigo Machida1, Jian-Chang Liu2, Claudine Kashiwabara2, Douglas Feldman2, Jeong Joseph Hyeongnam2, Lopa Mishra3, Hidekazu Tsukamoto2. 1Southern California Research Center for Alcoholic Liver and Pancreatic Diseases, Los Angeles, CA; 2University of Southern California, Los Angeles, CA; 3Georgetown University, Atlanta, GA | TLR4-dependent Nanog+ cancer stem cells exhibit defective TGF-β signaling through IGF-Akt-Yap1 pathway
PO.CG01.04.Viral Carcinogenesis and Hormonal Carcinogenesis |
|
Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 22 |
5426 Poster Session |
29 | Ahmed S. Sultan1, Zaki A. Sherif2. 1Alexandria University, Alexandria, Egypt; 2Georgetown University Medical Center, Washington, DC | New suppression strategy for human breast cancer invasion and metastasis
PO.ET01.07.Combination of Targeted Agents |
|
Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 28 |
5569 Poster Session |
16 | Zuzana Brnakova1, Kevin B. Chandler1, Slavka Bekesova1, Juraj Lenco1, Ionut Bebu1, Ourania Kosti1, Kirti Shetty1, Brent E. Korba2, Habtom W. Ressom1, Rency S. Varghese1, Milos V. Novotny3, Radoslav Goldman1. 1Georgetown University, Department of Oncology, Washington, DC; 2Georgetown University, Department of Microbiology and Immunology, Washington, DC; 3Indiana University, Department of Chemistry, Bloomington, IN | N-glycosylation in cultured cells and hepatocellular carcinoma
PO.CH03.02.Proteomics, Metabolomics, and Profiling |
|
Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 33 |
5659 Poster Session |
15 | Ashoka S. Rajendra, Shankar Jagadeesh, Partha P. Banerjee. Georgetown University, Washington, DC | Down-regulation of hTERT sensitizes chemotherapeutic effects of docetaxel in human prostate cancer cells via suppression of PIM-1 oncogene
PO.PR01.06.Mechanistic Insights into Cancer Prevention 2 |
|
Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 36 |
5728 Poster Session |
3 | James J. Goedert1, Laura A. Napolitano2, Yolana Lie3, Dawn Smith4, Alexandra Levine5, Mary Young6, Mardge Cohen7, Howard Minkoff8, Kathryn Anastos9, Gypsyamber D’Souza10, Ruth M. Greenblatt11, Nancy Hessol11. 1National Cancer Institute, Rockville, MD; 2Monogram Biosciences and University of California San Francisco, South San Francisco, CA; 3Monogram Bioscience, South San Francisco, CA; 4Centers for Disease Control and Prevention, Atlanta, GA; 5City of Hope National Medical Center, Duarte, CA; 6Georgetown University School of Medicine, Washington, DC; 7Stroger and Rush University School of Medicine, Chicago, IL; 8Maimonides Medical Center and State University of New York, Brooklyn, NY; 9Montefiore Medical Center, Bronx, NY; 10Johns Hopkins School of Public Health, Baltimore, MD; 11University of California San Francisco, San Francisco, CA | HIV tropism and decreased risk of breast cancer among women in the United States
PO.EP01.04.Inflammatory and Hormonal Factors in Relation to Cancer |
|
Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 36 |
5737 Poster Session |
12 | Julie R. Palmer1, Deborah A. Boggs1, Lucile L. Adams-Campbell2, Lynn Rosenberg1. 1Boston University, Boston, MA; 2Georgetown University, Washington, DC | Parity and lactation in relation to ER-/PR- breast cancer in African American women
PO.EP01.04.Inflammatory and Hormonal Factors in Relation to Cancer |
|
Wed 4/21 8:00 AM 8:00 AM – 11:00 AM Exhibit Hall A-C, Poster Section 36 |
5741 Poster Session |
16 | Celia Byrne1, Giske Ursin2, Christopher F. Martin3, Jennifer D. Peck4, Elodia B. Cole3, Gerardo Heiss5, Anne McTiernan6, Donglin Zeng5, Rowan T. Chlebowski7, Dorothy S. Lane8, JoAnn E. Manson9, Jean Wactawski-Wende10, Shagufta Yasmeen11, Norman F. Boyd12, Martin J. Yaffe13, Etta D. Pisano3. 1Lombardi Comp. Cancer Ctr. at Georgetown Univ., Washington, DC; 2Keck School of Medicine, University of Southern California, Los Angeles, CA; 3University of North Carolina School of Medicine, Chapel Hill, NC; 4The University of Oklahoma Health Sciences Center, Oklahoma City, OK; 5University of North Carolina School of Public Health, Chapel Hill, NC; 6Fred Hutchinson Cancer Research Center, Seattle, WA; 7University of California Los Angeles, School of Medicine, Los Angeles, CA; 8Stony Brook University School of Medicine, Stoney Brook, NY; 9Brigham and Women’s Hospital, Boston, MA; 10University at Buffalo, Buffalo, NY; 11University of California Davis Health System, Sacramento, CA; 12Ontario Cancer Institute, Toronto, ON, Canada; 13University of Toronto, Toronto, ON, Canada | Change in mammographic density with estrogen and progestin therapy: A measure of breast cancer risk in the Women’s Health Initiative
PO.EP01.04.Inflammatory and Hormonal Factors in Relation to Cancer |